Promising results of gene therapy to treat eye diseases
August 14th, 2010 - 3:44 pm ICT by ANI
Washington, Aug 14 (ANI): Scientists have made promising findings that offer hope for using gene therapy to treat eye diseases.
Two reports describe the effective replacement of a human gene to preserve photoreceptor function in a mouse model of severe retinal degeneration.
Basil Pawlyk and colleagues from Harvard Medical School and Massachusetts Eye and Ear Infirmary (Boston, MA) delivered the human gene for RGPR-interacting protein-1 to mice affected with Leber congenital amaurosis (LCA), a condition linked to a mutated form of RPGRIP1 that causes degeneration of photoreceptors in the eye.
The researchers packaged the gene in an adeno-associated virus (AAV) vector and injected the vector under the retinas of the affected mice.
They demonstrated expression of the human gene in the photoreceptors, with correct localization to the cilia.
Further evaluation revealed improved function and survival of the photoreceptors in the treated eyes.
The authors concluded that the results of this study validate a gene therapy design that could serve as the basis for a future clinical trial in patients affected by this form of LCA.
In the same issue, Kamolika Roy, Linda Stein, and Shalesh Kaushal from University of Massachusetts Medical School (Worcester) review the use of recombinant AAV vectors for gene therapy to treat ocular diseases.
Based on the success of three early-stage clinical trials in LCA, they conclude that this approach appears “to be a safe, effective, and long-term treatment for LCA, a previously untreatable disorder.”
In the second study, the researchers concluded that rAAV-mediated gene therapy is “the most suitable gene therapy treatment approach for ocular diseases.”
“The successful correction of this photoreceptor defect in a relevant mouse model of LCA should usher in a new wave of translational research in retinal degeneration syndromes,” said Dr. James M. Wilson, Editor-in-Chief of Human Gene Therapy.
The study has been published in the current issue of Human Gene Therapy. (ANI)
- New prosthetic device offers to hope to the visually impaired - Nov 19, 2010
- Breakthrough gene therapy could preserve vision - Aug 17, 2010
- Gene therapy to treat blindness on the anvil - Aug 01, 2009
- Night blindness cured in mice with special cells - Apr 19, 2012
- 'Novel treatment for advanced Parkinson's disease' found - Mar 17, 2011
- New study on lead exposure paves way for blindness treatment - Oct 26, 2010
- Study sheds light on inherited retinal disease - Jan 18, 2010
- Researchers isolate protective mechanism to save sight - Nov 17, 2009
- Stem cell therapy for age-related macular degeneration may soon be a reality - Mar 25, 2011
- Single shot of gene therapy could make kids with congenital blindness see - Oct 25, 2009
- New hope for restoring vision in the blind - Sep 22, 2010
- London hospital to do Europe's first embryonic stem cell trial - Sep 24, 2011
- Electronic implants to give sight back to blind - Nov 03, 2010
- Gene therapy for retinal degeneration may harbour blindness cure - Oct 17, 2008
- New treatment for severe eye disease found disease - Jul 22, 2010
Tags: aav vectors, congenital amaurosis, eye and ear infirmary, eye diseases, gene therapy treatment, harvard medical school, human gene therapy, kaushal, linda stein, massachusetts eye and ear infirmary, massachusetts medical school, mouse model, ocular diseases, photoreceptors, promising findings, promising results, retinal degeneration, retinas, university of massachusetts medical school, university of massachusetts medical school worcester